neurenpharma.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | Neuren |
| Description | Improving the lives of people with neurodevelopmental Neuren (ASX: NEU) has two drugs in clinical development for multiple serious neurological disorders that emerge in early childhood, for which currently there are no approved drug |
| Keywords | Neuren, Neuren Pharmaceuticals, ASX: NEU, NEU, neurodevelopmental disabilities, clinical trials |
Server Information
| WebSite | |
| Host IP | 54.79.124.122 |
| Location | Australia |
Related Websites
| Site | Rank |
More to Explore
neurenpharma.com Valuation
|
US$5,813,578
Last updated: 2023-05-08 15:38:56
neurenpharma.com has Semrush global rank of 1,820,618. neurenpharma.com has an estimated worth of US$ 5,813,578, based on its estimated Ads revenue. neurenpharma.com receives approximately 670,798 unique visitors each day. Its web server is located in Australia, with IP address 54.79.124.122. According to SiteAdvisor, neurenpharma.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$5,813,578 |
| Daily Ads Revenue | US$5,367 |
| Monthly Ads Revenue | US$160,992 |
| Yearly Ads Revenue | US$1,931,897 |
| Daily Unique Visitors | 44,720 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| neurenpharma.com. | A | 300 | IP: 54.79.124.122 |
| neurenpharma.com. | NS | 86400 | NS Record: ns13.dnsmadeeasy.com. |
| neurenpharma.com. | NS | 86400 | NS Record: ns11.dnsmadeeasy.com. |
| neurenpharma.com. | NS | 86400 | NS Record: ns10.dnsmadeeasy.com. |
| neurenpharma.com. | NS | 86400 | NS Record: ns12.dnsmadeeasy.com. |
| neurenpharma.com. | NS | 86400 | NS Record: ns14.dnsmadeeasy.com. |
| neurenpharma.com. | NS | 86400 | NS Record: ns15.dnsmadeeasy.com. |
| neurenpharma.com. | MX | 14400 | MX Record: 20 filter2.neuren-1.mailguard.com.au. |
| neurenpharma.com. | MX | 14400 | MX Record: 10 filter1.neuren-1.mailguard.com.au. |
| neurenpharma.com. | MX | 14400 | MX Record: 30 filter3.neuren-1.mailguard.com.au. |
| neurenpharma.com. | TXT | 3600 | TXT Record: MS=ms74840682 |
| neurenpharma.com. | TXT | 3600 | TXT Record: v=spf1 ip4:165.228.45.134 ip4:59.167.112.195 ip4:59.167.112.193 include:customer.mailguard.com.au include:spf.protection.outlook.com ~all |
HtmlToTextCheckTime:2023-05-08 15:38:56
| Subscribe to our Email Alerts Menu Home About Us Company Overview Company Values Board of Directors Management Corporate Directory Products DAYBUE™ (trofinetide) Pipeline Pipeline Trofinetide Rett Syndrome Fragile X Syndrome NNZ-2591 Phelan-McDermid Syndrome Angleman Syndrome Pitt Hopkins Syndrome Prader-Willi Syndrome Science Science Behind Neuren’s Products Scientific Presentations Publications Investors Investor Dashboard Share Price Information ASX Announcements Annual and Interim Reports Investor Presentations Corporate Governance Analyst Coverage Shareholder Services News & Media Media Contact Contact Us Email Alerts FDA Approves DAYBUE™ (trofinetide). Click here to learn more Improving the lives of people with neurodevelopmental disabilities So your online presence really delivers at each step Learn more Improving the lives of people with neurodevelopmental disabilities So your online presence really delivers at each step Learn more Improving the lives of people with |
HTTP Headers
HTTP/1.1 301 Moved Permanently Content-Length: 145 Content-Type: text/html; charset=utf-8 Location: http://www.neurenpharma.com/ Strict-Transport-Security: max-age=31536000 Date: Sat, 30 Oct 2021 07:14:03 GMT HTTP/1.1 302 Found Cache-Control: private Cache-control: no-cache="set-cookie" Content-Length: 142 Content-Type: text/html; charset=utf-8 Date: Sat, 30 Oct 2021 07:14:04 GMT Location: /IRM/content/default.aspx Set-Cookie: AWSELB=6513754B1C5CC94C36D4FA97FE6911DC2DDBF7E465F080A728F3B5B668C02DDFEF36CD5A71C27E7A01616814D2D5248271BDE8AF0B06B7ECAAD740E2288EEE78DA66F8C697;PATH=/;MAX-AGE=600 Strict-Transport-Security: max-age=31536000 Connection: keep-alive HTTP/1.1 302 Found Cache-control: no-cache="set-cookie" Content-Length: 170 Content-Type: text/html; charset=utf-8 Date: Sat, 30 Oct 2021 07:14:04 GMT Location: https://www.neurenpharma.com/IRM/content/default.aspx Set-Cookie: AWSELB=6513754B1C5CC94C36D4FA97FE6911DC2DDBF7E46578628D015A9121F2184A1C3FF9BF0642C27E7A01616814D2D5248271BDE8AF0BEC647D418D1169CD37248CA537D3FA62;PATH=/;MAX-AGE=600 Strict-Transport-Security: max-age=31536000 Connection: keep-alive HTTP/2 200 cache-control: private content-length: 20071 content-type: text/html; charset=utf-8 set-cookie: ASP.NET_SessionId=re2a1ncjym1yhw31gydpc0jz; path=/; secure; HttpOnly; SameSite=Lax strict-transport-security: max-age=31536000 date: Sat, 30 Oct 2021 07:14:05 GMT |
neurenpharma.com Whois Information
Domain Name: NEURENPHARMA.COM Registry Domain ID: 116444812_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.rrpproxy.net Registrar URL: http://www.key-systems.net Updated Date: 2021-03-08T03:05:43Z Creation Date: 2004-04-07T19:47:03Z Registry Expiry Date: 2022-04-07T19:47:03Z Registrar: Key-Systems GmbH Registrar IANA ID: 269 Registrar Abuse Contact Email: abuse@key-systems.net Registrar Abuse Contact Phone: +49.68949396850 Domain Status: ok https://icann.org/epp#ok Name Server: NS10.DNSMADEEASY.COM Name Server: NS11.DNSMADEEASY.COM Name Server: NS12.DNSMADEEASY.COM Name Server: NS13.DNSMADEEASY.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-17T17:59:25Z <<< |